167 related articles for article (PubMed ID: 19134161)
21. Application of cyclophosphamide-induced tolerance in alpha1,3-galactosyltransferase knockout mice presensitized with Gal alpha 1-3Gal beta-4-GlcNAc antigens.
Onzuka T; Shimizu I; Tomita Y; Iwai T; Okano S; Tominaga R
Surg Today; 2008; 38(9):807-14. PubMed ID: 18751946
[TBL] [Abstract][Full Text] [Related]
22. Intra-bone Bone Marrow Transplantation in Pig-to-Nonhuman Primates for the Induction of Tolerance Across Xenogeneic Barriers.
Yamada K; Ariyoshi Y; Pomposelli T; Takeuchi K
Methods Mol Biol; 2020; 2110():213-225. PubMed ID: 32002911
[TBL] [Abstract][Full Text] [Related]
23. Additional monoclonal antibody (mAB) injections can replace thymic irradiation to allow induction of mixed chimerism and tolerance in mice receiving bone marrow transplantation after conditioning with anti-T cell mABs and 3-Gy whole body irradiation.
Tomita Y; Sachs DH; Khan A; Sykes M
Transplantation; 1996 Feb; 61(3):469-77. PubMed ID: 8610363
[TBL] [Abstract][Full Text] [Related]
24. Bone marrow transplantation from alpha1,3-galactosyltransferase gene-knockout pigs in baboons.
Tseng YL; Dor FJ; Kuwaki K; Ryan D; Wood J; Denaro M; Giovino M; Yamada K; Hawley R; Patience C; Schuurman HJ; Awwad M; Sachs DH; Cooper DK
Xenotransplantation; 2004 Jul; 11(4):361-70. PubMed ID: 15196131
[TBL] [Abstract][Full Text] [Related]
25. Use of lentiviral vectors to induce long-term tolerance to gal(+) heart grafts.
Kearns-Jonker M; Fischer-Lougheed J; Shulkin I; Kleihauer A; Mitsuhashi N; Kohn DB; Weinberg K; D'Apice AJ; Starnes VA; Cramer DV
Transplantation; 2004 Jun; 77(11):1748-54. PubMed ID: 15201677
[TBL] [Abstract][Full Text] [Related]
26. Intragraft gene expression profile associated with the induction of tolerance.
Doki T; Mello M; Mock D; Evans JM; Kearns-Jonker M
BMC Immunol; 2008 Feb; 9():5. PubMed ID: 18267024
[TBL] [Abstract][Full Text] [Related]
27. Glycolipid studies in small intestine and pancreas of alpha1,3-galactosyltransferase knockout miniature swine: alpha1,3GALT-KO animals lack alphaGAL antigens and contain novel blood group H compounds.
Diswall M; Angström J; Schuurman HJ; Dor FJ; Rydberg L; Breimer ME
Transplant Proc; 2008 Mar; 40(2):543-6. PubMed ID: 18374124
[TBL] [Abstract][Full Text] [Related]
28. Effect of αGal on corneal xenotransplantation in a mouse model.
Choi HJ; Kim MK; Lee HJ; Jeong SH; Kang HJ; Park CS; Park CG; Joon Kim S; Wee WR
Xenotransplantation; 2011; 18(3):176-82. PubMed ID: 21696447
[TBL] [Abstract][Full Text] [Related]
29. Tolerance induction to a mammalian blood group-like carbohydrate antigen by syngeneic lymphocytes expressing the antigen, II: tolerance induction on memory B cells.
Mohiuddin MM; Ogawa H; Yin DP; Galili U
Blood; 2003 Jul; 102(1):229-36. PubMed ID: 12649147
[TBL] [Abstract][Full Text] [Related]
30. Decay-accelerating factor prevents acute humoral rejection induced by low levels of anti-alphaGal natural antibodies.
Shimizu I; Smith NR; Zhao G; Medof E; Sykes M
Transplantation; 2006 Jan; 81(1):95-100. PubMed ID: 16421483
[TBL] [Abstract][Full Text] [Related]
31. Humoral tolerance in xenogeneic BMT recipients conditioned by a nonmyeloablative regimen.
Aksentijevich I; Sachs DH; Sykes M
Transplantation; 1992 May; 53(5):1108-14. PubMed ID: 1585475
[TBL] [Abstract][Full Text] [Related]
32. Xenogeneic thymokidney and thymic tissue transplantation in a pig-to-baboon model: I. Evidence for pig-specific T-cell unresponsiveness.
Barth RN; Yamamoto S; LaMattina JC; Kumagai N; Kitamura H; Vagefi PA; Awwad M; Colvin RB; Cooper DK; Sykes M; Sachs DH; Yamada K
Transplantation; 2003 May; 75(10):1615-24. PubMed ID: 12777846
[TBL] [Abstract][Full Text] [Related]
33. Intact active bone transplantation synergizes with anti-CD40 ligand therapy to induce B cell tolerance.
Yin D; Ma L; Varghese A; Shen J; Chong AS
J Immunol; 2002 May; 168(10):5352-8. PubMed ID: 11994494
[TBL] [Abstract][Full Text] [Related]
34. Transgenic expression of human CD47 markedly increases engraftment in a murine model of pig-to-human hematopoietic cell transplantation.
Tena A; Kurtz J; Leonard DA; Dobrinsky JR; Terlouw SL; Mtango N; Verstegen J; Germana S; Mallard C; Arn JS; Sachs DH; Hawley RJ
Am J Transplant; 2014 Dec; 14(12):2713-22. PubMed ID: 25278264
[TBL] [Abstract][Full Text] [Related]
35. Anti-Gal antibody-mediated allograft rejection in alpha1,3-galactosyltransferase gene knockout mice: a model of delayed xenograft rejection.
Pearse MJ; Witort E; Mottram P; Han W; Murray-Segal L; Romanella M; Salvaris E; Shinkel TA; Goodman DJ; d'Apice AJ
Transplantation; 1998 Sep; 66(6):748-54. PubMed ID: 9771838
[TBL] [Abstract][Full Text] [Related]
36. Anti-CD154 or CTLA4Ig obviates the need for thymic irradiation in a non-myeloablative conditioning regimen for the induction of mixed hematopoietic chimerism and tolerance.
Wekerle T; Sayegh MH; Ito H; Hill J; Chandraker A; Pearson DA; Swenson KG; Zhao G; Sykes M
Transplantation; 1999 Nov; 68(9):1348-55. PubMed ID: 10573075
[TBL] [Abstract][Full Text] [Related]
37. Complete protection against melanoma in absence of autoimmune depigmentation after rejection of melanoma cells expressing alpha(1,3)galactosyl epitopes.
Rossi GR; Unfer RC; Seregina T; Link CJ
Cancer Immunol Immunother; 2005 Oct; 54(10):999-1009. PubMed ID: 15889257
[TBL] [Abstract][Full Text] [Related]
38. Suppression of Lewis lung tumor development in alpha 1,3 galactosyltransferase knock-out mice.
Posekany KJ; Pittman HK; Swanson MS; Haisch CE; Verbanac KM
Anticancer Res; 2004; 24(2B):605-12. PubMed ID: 15161001
[TBL] [Abstract][Full Text] [Related]
39. The role of T cell help in the production of antibodies specific for Gal alpha 1-3Gal.
Cretin N; Bracy J; Hanson K; Iacomini J
J Immunol; 2002 Feb; 168(3):1479-83. PubMed ID: 11801692
[TBL] [Abstract][Full Text] [Related]
40. Characteristics of α-Gal epitope, anti-Gal antibody, α1,3 galactosyltransferase and its clinical exploitation (Review).
Huai G; Qi P; Yang H; Wang Y
Int J Mol Med; 2016 Jan; 37(1):11-20. PubMed ID: 26531137
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
